Canon (7751) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
15 Oct, 2026Executive summary
FY 2023 net sales rose 3.7% to ¥4,181.0B, operating profit increased 6.2% to ¥375.4B and net income attributable to shareholders rose 8.4% to ¥264.5B, marking a third consecutive year of growth.
Results benefited from new businesses, recovering product supplies, yen depreciation, and lower component and logistics costs, despite delayed purchases and inventory reductions in some markets.
Financial highlights
FY 2023 gross profit rose 7.7% to ¥1,968.9B; operating expenses increased 8.1% to ¥1,593.5B. Gross margin was 47.1%, up from 45.3%.
Operating profit was ¥375.4B, 9.0% of sales; income before tax rose 10.9% to ¥390.8B and net income attributable to shareholders increased 8.4% to ¥264.5B.
Q4 net sales were ¥1,163.7B (+0.6% YoY), operating profit ¥116.0B (+19.2%) and net income attributable to shareholders ¥80.6B (-5.0%).
FY operating profit increased ¥22.0B; FX contributed ¥59.7B, partly offset by sales volume/mix, pricing, costs and operating expenses.
Outlook and guidance
FY 2024 guidance: net sales ¥4,350.0B (+4.0%), operating profit ¥435.0B (+15.9%), 10.0% operating margin, income before tax ¥450.0B (+15.2%) and net income ¥305.0B (+15.3%).
FY 2024 projected gross margin is 47.5% and operating expense ratio 37.5%; exchange-rate assumptions are ¥140 per US dollar and ¥155 per euro.
Growth drivers include semiconductor lithography, Medical, network cameras, commercial printing, office MFDs and new interchangeable-lens camera products; FPD lithography is expected to improve in H2.
A fourth consecutive year of sales and profit growth is targeted; the operating-profit bridge includes contributions from sales volume/product mix and pricing, partly offset by costs and operating expenses.
Annual operating-profit sensitivity is ¥3.0B per ¥1 move in either the US dollar or euro exchange rate.
Latest events from Canon
- Record 3Q sales and Imaging-led growth, tempered by Medical delays and lower FY guidance.7751
Q3 2026 - Record sales and profit growth led to a raised outlook, driven by Imaging and Printing.7751
Q2 2026 - Record 1Q sales up 3.3% YoY, but profit and net income fell on higher costs and tariffs.7751
Q1 2026 - Record sales and profit growth in 2025, with further gains and higher margins projected for 2026.7751
Q4 2025 - Record sales offset by profit pressure from tariffs; guidance lowered, dividend raised.7751
Q3 2025 - Profitability improved in local currency, but full-year guidance was revised downward.7751
Q2 2025 - Record sales and profit growth in Q3 2024, led by Printing and Imaging, with a strong full-year outlook.7751
Q3 2024 - Record Q2 sales and profit growth, with raised full-year outlook and strong segment results.7751
Q2 2024 - Record sales in 2024, Medical goodwill hit, but 2025 profit rebound expected.7751
Q4 2024